UroGen Pharma Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 02/14/2025 | 3.83 M | $40.84 M | 1.25% | 8.90% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 2.93 M | $31.18 M | -21.62% | 6.79% |
| BLACKROCK, INC. | 02/07/2025 | 2.47 M | $26.28 M | -1.23% | 5.72% |
| MENORA MIVTACHIM HOLDINGS LTD. | 02/13/2025 | 2.30 M | $24.53 M | 0.00% | 5.34% |
| TORONTO DOMINION BANK | 02/19/2025 | 1.75 M | $18.63 M | 100.00% | 4.06% |
| VESTAL POINT CAPITAL, LP | 02/14/2025 | 1.63 M | $17.36 M | 307.50% | 3.78% |
| 02/14/2025 | 1.52 M | $16.15 M | 100.00% | 3.52% | |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 1.38 M | $14.67 M | 2.69% | 3.20% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.37 M | $14.61 M | 100.00% | 3.18% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.12 M | $11.93 M | 24.34% | 2.60% |
| JEFFERIES FINANCIAL GROUP INC. | 02/27/2025 | 965,929 | $10.29 M | 0.10% | 2.24% |
| UBS GROUP AG | 02/14/2025 | 922,698 | $9.83 M | 1,915.72% | 2.14% |
| ROSALIND ADVISORS, INC. | 02/14/2025 | 870,000 | $9.27 M | 100.00% | 2.02% |
| STATE STREET CORP | 02/14/2025 | 808,053 | $8.61 M | 5.00% | 1.87% |
| MORGAN STANLEY | 02/14/2025 | 767,300 | $8.17 M | -64.83% | 1.78% |
| MIGDAL INSURANCE & FINANCIAL HOLDINGS LTD. | 01/28/2025 | 686,472 | $7.31 M | 0.00% | 1.59% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 645,785 | $6.88 M | -56.92% | 1.50% |
| WILDCAT CAPITAL MANAGEMENT, LLC | 01/29/2025 | 495,606 | $5.28 M | 0.00% | 1.15% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 492,515 | $5.25 M | 7.32% | 1.14% |
| HAREL INSURANCE INVESTMENTS & FINANCIAL SERVICES LTD. | 01/21/2025 | 463,267 | $4.93 M | 0.00% | 1.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 461,902 | $4.92 M | 1.38% | 1.07% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 393,984 | $4.20 M | 2,968.65% | 0.91% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/14/2025 | 369,861 | $3.94 M | 6.42% | 0.86% |
| CANTOR FITZGERALD, L. P. | 02/14/2025 | 360,000 | $3.79 M | 100.00% | 0.84% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 324,324 | $3.45 M | 15.69% | 0.75% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 317,522 | $3.38 M | 0.50% | 0.74% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 317,114 | $3.38 M | -78.95% | 0.74% |
| NORTHERN TRUST CORP | 02/14/2025 | 310,074 | $3.30 M | 8.14% | 0.72% |
| WOODLINE PARTNERS LP | 02/14/2025 | 305,642 | $3.26 M | 0.00% | 0.71% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 02/14/2025 | 301,206 | $3.21 M | 100.00% | 0.70% |
| CORMORANT ASSET MANAGEMENT, LP | 02/14/2025 | 300,000 | $3.20 M | -80.65% | 0.70% |
| VANGUARD GROUP INC | 02/11/2025 | 297,354 | $3.17 M | 4.54% | 0.69% |
| RICE HALL JAMES & ASSOCIATES, LLC | 01/31/2025 | 264,031 | $2.81 M | -2.89% | 0.61% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2025 | 233,322 | $2.48 M | 100.00% | 0.54% |
| CITADEL ADVISORS LLC | 02/14/2025 | 228,785 | $2.44 M | -5.49% | 0.53% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 221,540 | $2.36 M | 2.69% | 0.51% |
| OPALEYE MANAGEMENT INC. | 02/14/2025 | 220,000 | $2.34 M | -45.56% | 0.51% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 199,259 | $2.12 M | 751.53% | 0.46% |
| GREAT POINT PARTNERS LLC | 02/14/2025 | 187,843 | $2.00 M | -75.24% | 0.44% |
| TREXQUANT INVESTMENT LP | 02/12/2025 | 172,551 | $1.84 M | -36.49% | 0.40% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 146,953 | $1.57 M | 7.03% | 0.34% |
| ATOM INVESTORS LP | 02/14/2025 | 145,732 | $1.55 M | 100.00% | 0.34% |
| ARK INVESTMENT MANAGEMENT LLC | 02/04/2025 | 140,148 | $1.49 M | 15.22% | 0.33% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 138,200 | $1.47 M | 100.00% | 0.32% |
| MARSHALL WACE, LLP | 02/13/2025 | 136,491 | $1.45 M | 100.00% | 0.32% |
| EPOCH INVESTMENT PARTNERS, INC. | 02/13/2025 | 125,688 | $1.34 M | -8.17% | 0.29% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 93,997 | $1.00 M | 7.34% | 0.22% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 93,517 | $995,956 | 3.34% | 0.22% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 92,957 | $989,992 | -37.77% | 0.22% |
| DE LISLE PARTNERS LLP | 02/13/2025 | 81,510 | $867,674 | 0.00% | 0.19% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
UroGen Pharma Ltd. institutional Ownership - FAQ's
During the previous two years, 162 institutional investors and hedge funds held shares of UroGen Pharma Ltd.. The most heavily invested institutionals were:
RTW INVESTMENTS, LP: 3.83 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 2.93 M
BlackRock, Inc.: 2.47 M
MENORA MIVTACHIM HOLDINGS LTD.: 2.3 M
TORONTO DOMINION BANK: 1.75 M
Vestal Point Capital, LP: 1.63 M
84.16% of UroGen Pharma Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 42.06 M shares in the last 24 months. This purchase volume represents approximately $425.63 M in transactions.